Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update

被引:99
作者
Atluri, Venkata Subba Rao [1 ]
Hidalgo, Melissa [1 ]
Samikkannu, Thangavel [1 ]
Kurapati, Kesava Rao Venkata [1 ]
Jayant, Rahul Dev [1 ]
Sagar, Vidya [1 ]
Nair, Madhavan P. N. [1 ]
机构
[1] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33199 USA
关键词
HIV; gp120; Tat; Nef; Vpr; blood-brain barrier; neurocognitive disorders; HIV-1 TAT PROTEIN; POLYMERASE-CHAIN-REACTION; JUNCTIONAL INTERCELLULAR COMMUNICATION; MICROVASCULAR ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; NUCLEAR-LOCALIZATION; MONOCYTE MIGRATION; HUMAN ASTROCYTES; GAP-JUNCTIONS;
D O I
10.3389/fncel.2015.00212
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The blood-brain barrier (BBB) is a diffusion barrier that has an important role in maintaining a precisely regulated microenvironment protecting the neural tissue from infectious agents and toxins in the circulating system. Compromised BBB integrity plays a major role in the pathogenesis of retroviral associated neurological diseases. Human Immunodeficiency Virus (HIV) infection in the Central Nervous System (CNS) is an early event even before the serodiagnosis for HIV positivity or the initiation of antiretroviral therapy (ART), resulting in neurological complications in many of the infected patients. Macrophages, microglia and astrocytes (in low levels) are the most productively/latently infected cell types within the CNS. In this brief review, we have discussed about the effect of HIV infection and viral proteins on the integrity and function of BBB, which may contribute to the progression of HIV associated neurocognitive disorders.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 98 条
[31]   HIV-1: Fifteen proteins and an RNA [J].
Frankel, AD ;
Young, JAT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :1-25
[32]  
Goldstein G W, 1988, Ann N Y Acad Sci, V529, P31, DOI 10.1111/j.1749-6632.1988.tb51417.x
[33]   The neuropathogenesis of AIDS [J].
González-Scarano, F ;
Martín-García, J .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (01) :69-81
[34]   Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells [J].
Guduru, Rakesh ;
Liang, Ping ;
Runowicz, Carolyn ;
Nair, Madhavan ;
Atluri, Venkata ;
Khizroev, Sakhrat .
SCIENTIFIC REPORTS, 2013, 3
[35]   MURINE TUMOR-NECROSIS-FACTOR-ALPHA IS TRANSPORTED FROM BLOOD TO BRAIN IN THE MOUSE [J].
GUTIERREZ, EG ;
BANKS, WA ;
KASTIN, AJ .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 47 (02) :169-176
[36]   The blood-brain barrier/neurovascular unit in health and disease [J].
Hawkins, BT ;
Davis, TP .
PHARMACOLOGICAL REVIEWS, 2005, 57 (02) :173-185
[37]  
Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO
[38]  
2-E
[39]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRAL-PROTEIN-R (VPR) ARRESTS CELLS IN THE G(2) PHASE OF THE CELL-CYCLE BY INHIBITING P34(CDC2) ACTIVITY [J].
HE, JL ;
CHOE, S ;
WALKER, R ;
DIMARZIO, P ;
MORGAN, DO ;
LANDAU, NR .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6705-6711
[40]   THE VPR PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFLUENCES NUCLEAR-LOCALIZATION OF VIRAL NUCLEIC-ACIDS IN NONDIVIDING HOST-CELLS [J].
HEINZINGER, NK ;
BUKRINSKY, MI ;
HAGGERTY, SA ;
RAGLAND, AM ;
KEWALRAMANI, V ;
LEE, MA ;
GENDELMAN, HE ;
RATNER, L ;
STEVENSON, M ;
EMERMAN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7311-7315